ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome

 

Stay Connected

Follow us on social media

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook